FHIR data delivers value in US healthcare when applied to specific problems. Five applications ship real ROI in 2026.
1. Population risk stratification. Bulk export feeds risk models. Bulk Data IG makes this operationally viable. Best for chronic condition management, prevention programs.
2. Clinical decision support. CDS Hooks fires alerts and suggestions at order-select and order-sign. Best for drug interactions, dosing, coverage requirements.
3. Care gap identification. Measure evaluations against clinical data identify patients missing recommended screenings, medications, follow-ups. Best for quality reporting and outreach programs.
4. Regulatory attestation. CMS-0057 requires structured FHIR reporting. MeasureReport as output.
5. Third-party app ecosystem. SMART on FHIR launched apps deliver point-of-care value from patient-owned devices, specialized clinical tools, patient engagement platforms.
Data quality prerequisites
FHIR data value depends on data quality. Tracking metrics predicts application success:
| Metric | Target for application success |
|---|---|
$validate pass rate |
>97% |
| Reference integrity | >99% |
| Terminology binding compliance | >98% |
| Duplicate rate | <2% |
Value acceleration
Sites with 3+ FHIR data applications shipping simultaneously outperform sites with 1. Common patterns compound:
- Population risk stratification + care gap ID → outreach effectiveness lifts 20-30%. - CDS Hooks + drug pricing → cost-of-care visibility improves. - Regulatory attestation + SMART ecosystem → third-party innovation accelerates.
Implementation order
1. Regulatory attestation (required, forcing function). 2. SMART on FHIR ecosystem (enable innovation). 3. Care gap identification (visible ROI). 4. Risk stratification (analytics investment). 5. CDS Hooks (in-workflow value).
FHIR data applications are now mainstream. Sites that pick 3-5 and ship focused execute better than sites trying to do all five simultaneously.